HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ming-Kuan Chyan Selected Research

Neoplasms (Cancer)

1/2023Design and synthesis of astatinated benzothiazole compounds for their potential use in Targeted Alpha Therapy (TAT) strategies to treat Alzheimer's disease-associated amyloid plaques.
9/2022Oxidation of p-[125I]Iodobenzoic Acid and p-[211At]Astatobenzoic Acid Derivatives and Evaluation In Vivo.
6/2011Reagents for astatination of biomolecules. 5. Evaluation of hydrazone linkers in (211)At- and (125)I-labeled closo-decaborate(2-) conjugates of Fab' as a means of decreasing kidney retention.
7/2010Design and synthesis of bis-biotin-containing reagents for applications utilizing monoclonal antibody-based pretargeting systems with streptavidin mutants.
1/2008Streptavidin in antibody pretargeting. 5. chemical modification of recombinant streptavidin for labeling with the alpha-particle-emitting radionuclides 213Bi and 211At.
5/2004Biotin reagents in antibody pretargeting. 6. Synthesis and in vivo evaluation of astatinated and radioiodinated aryl- and nido-carboranyl-biotin derivatives.
5/2002A streptavidin-biotin binding system that minimizes blocking by endogenous biotin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ming-Kuan Chyan Research Topics

Disease

7Neoplasms (Cancer)
01/2023 - 05/2002
1Amyloid Plaque
01/2023
1Alzheimer Disease (Alzheimer's Disease)
01/2023
1Neurodegenerative Diseases (Neurodegenerative Disease)
01/2023
1Tauopathies
01/2023
1Prostatic Neoplasms (Prostate Cancer)
01/2021
1Blood-Borne Infections
11/2019
1Hematologic Neoplasms (Hematological Malignancy)
01/2018
1Infertility (Sterility)
01/2018
1Lymphoma (Lymphomas)
07/2010

Drug/Important Bio-Agent (IBA)

5Radioisotopes (Radionuclides)IBA
09/2022 - 01/2008
4Astatine-211IBA
09/2022 - 06/2011
3Proteins (Proteins, Gene)FDA Link
01/2021 - 07/2010
3Indicators and Reagents (Reagents)IBA
06/2011 - 05/2004
3Biotin (Vitamin H)FDA Link
07/2010 - 05/2002
3StreptavidinIBA
07/2010 - 05/2002
1benzothiazoleIBA
01/2023
1Amyloid (Amyloid Fibrils)IBA
01/2023
1human FOLH1 proteinIBA
01/2021
1Urea (Carbamide)FDA LinkGeneric
01/2021
1Lysine (L-Lysine)FDA Link
01/2021
1Glutamic Acid (Glutamate)FDA Link
01/2021
1AntibodiesIBA
01/2018
1PyrogensIBA
01/2018
1Monoclonal AntibodiesIBA
06/2011
1GalactosamineIBA
07/2010
1Single-Chain AntibodiesIBA
07/2010
1DOTA-biotin (90Y-DOTA-biotin)IBA
07/2010

Therapy/Procedure

6Therapeutics
01/2023 - 05/2002
1Radiotherapy
09/2022
1Cell Transplantation
01/2018
1Radioimmunotherapy
05/2002